{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:09:55Z","timestamp":1791216595205,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,17]],"date-time":"2010-03-17T00:00:00Z","timestamp":1268784000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Irritable bowel syndrome (IBS) is associated with other disorders (comorbidity), reduced quality of life and increased use of health resources. We aimed to explore the impact of comorbidity on cost of health care in patients with IBS in general practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this cohort study 208 consecutive patients with IBS (Rome II) were recruited. Sociodemographic data, IBS symptoms, and comorbidity (somatic symptoms, organic diseases and psychiatric disorders) were assessed at baseline. Based on a follow up interview after 6-9 months and use of medical records, IBS and non-IBS related health resource use were measured as consultations, hospitalisations, use of medications and alternative health care products and sick leave days. Costs were calculated by national tariffs and reported in Norwegian Kroner (NOK, 1 EURO equals 8 NOK). Multivariate analyses were performed to identify predictors of costs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 164 patients (mean age 52 years, 69% female, median duration of IBS 17 years) were available at follow up, 143 patients (88%) had consulted their GP of whom 31 (19%) had consulted for IBS. Mean number of sick- leave days for IBS and comorbidity were 1.7 and 16.3 respectively (p &lt; 0.01), costs related to IBS and comorbidity were 954 NOK and 14854 NOK respectively (p &lt; 0.001). Age, organic diseases and somatic symptoms, but not IBS severity, were significant predictors for total costs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Costs for health resource use among patients with IBS in general practice were largely explained by comorbidity, which generated ten times the costs for IBS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-230x-10-31","type":"journal-article","created":{"date-parts":[[2010,3,17]],"date-time":"2010-03-17T07:13:46Z","timestamp":1268810026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice"],"prefix":"10.1186","volume":"10","author":[{"given":"Per A","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per G","family":"Farup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bracco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per O","family":"Vandvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,17]]},"reference":[{"key":"422_CR1","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/BF01303162","volume":"38","author":"DA Drossman","year":"1993","unstructured":"Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al: U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993, 38: 1569-1580. 10.1007\/BF01303162.","journal-title":"Dig Dis Sci"},{"key":"422_CR2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1365-2036.2003.01456.x","volume":"17","author":"AP Hungin","year":"2003","unstructured":"Hungin AP, Whorwell PJ, Tack J, Mearin F: The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther. 2003, 17: 643-650. 10.1046\/j.1365-2036.2003.01456.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"422_CR3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1080\/00365520500442542","volume":"41","author":"PO Vandvik","year":"2006","unstructured":"Vandvik PO, Lydersen S, Farup PG: Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol. 2006, 41: 650-656. 10.1080\/00365520500442542.","journal-title":"Scand J Gastroenterol"},{"key":"422_CR4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2165\/00019053-200220110-00004","volume":"20","author":"X Badia","year":"2002","unstructured":"Badia X, Mearin F, Balboa A, Baro E, Caldwell E, Cucala M, et al: Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics. 2002, 20: 749-758. 10.2165\/00019053-200220110-00004.","journal-title":"Pharmacoeconomics"},{"key":"422_CR5","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1046\/j.1365-2036.2002.01290.x","volume":"16","author":"HB El-Serag","year":"2002","unstructured":"El-Serag HB, Olden K, Bjorkman D: Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther. 2002, 16: 1171-1185. 10.1046\/j.1365-2036.2002.01290.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"422_CR6","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1111\/j.1572-0241.2005.00269.x","volume":"100","author":"BM Spiegel","year":"2005","unstructured":"Spiegel BM, Kanwal F, Naliboff B, Mayer E: The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome. Am J Gastroenterol. 2005, 100: 2262-2273. 10.1111\/j.1572-0241.2005.00269.x.","journal-title":"Am J Gastroenterol"},{"key":"422_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00019053-200624010-00002","volume":"24","author":"S Maxion-Bergemann","year":"2006","unstructured":"Maxion-Bergemann S, Thielecke F, Abel F, Bergemann R: Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics. 2006, 24: 21-37. 10.2165\/00019053-200624010-00002.","journal-title":"Pharmacoeconomics"},{"key":"422_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2165\/00019053-200220070-00003","volume":"20","author":"RL Akehurst","year":"2002","unstructured":"Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, et al: Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics. 2002, 20: 455-462. 10.2165\/00019053-200220070-00003.","journal-title":"Pharmacoeconomics"},{"key":"422_CR9","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1053\/gast.2002.32392","volume":"122","author":"WE Whitehead","year":"2002","unstructured":"Whitehead WE, Palsson O, Jones KR: Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology. 2002, 122: 1140-1156. 10.1053\/gast.2002.32392.","journal-title":"Gastroenterology"},{"key":"422_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/j.1365-2036.2004.02250.x","volume":"20","author":"PO Vandvik","year":"2004","unstructured":"Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG: Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther. 2004, 20: 1195-1203. 10.1111\/j.1365-2036.2004.02250.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 2","key":"422_CR11","first-page":"II43","volume":"45","author":"WG Thompson","year":"1999","unstructured":"Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA: Functional bowel disorders and functional abdominal pain. Gut. 1999, 45 (Suppl 2): II43-II47.","journal-title":"Gut"},{"key":"422_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/14034948990270010401","volume":"27","author":"HR Eriksen","year":"1999","unstructured":"Eriksen HR, Ihlebaek C, Ursin H: A scoring system for subjective health complaints (SHC). Scand J Public Health. 1999, 27: 63-72. 10.1177\/14034948990270010401.","journal-title":"Scand J Public Health"},{"key":"422_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0022-3956(86)90005-1","volume":"20","author":"DA Grayson","year":"1986","unstructured":"Grayson DA: Latent trait analysis of the Eysenck Personality Questionnaire. J Psychiatr Res. 1986, 20: 217-235. 10.1016\/0022-3956(86)90005-1.","journal-title":"J Psychiatr Res"},{"key":"422_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0022-3999(95)00561-7","volume":"40","author":"AE Speckens","year":"1996","unstructured":"Speckens AE, Spinhoven P, Sloekers PP, Bolk JH, van Hemert AM: A validation study of the Whitely Index, the Illness Attitude Scales, and the Somatosensory Amplification Scale in general medical and general practice patients. J Psychosom Res. 1996, 40: 95-104. 10.1016\/0022-3999(95)00561-7.","journal-title":"J Psychosom Res"},{"key":"422_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/08039480310000932","volume":"57","author":"BH Strand","year":"2003","unstructured":"Strand BH, Dalgard OS, Tambs K, Rognerud M: Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nord J Psychiatry. 2003, 57: 113-118. 10.1080\/08039480310000932.","journal-title":"Nord J Psychiatry"},{"key":"422_CR16","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1111\/j.1572-0241.2001.03789.x","volume":"96","author":"NA Koloski","year":"2001","unstructured":"Koloski NA, Talley NJ, Boyce PM: Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol. 2001, 96: 1340-1349. 10.1111\/j.1572-0241.2001.03789.x.","journal-title":"Am J Gastroenterol"},{"key":"422_CR17","doi-asserted-by":"publisher","first-page":"860","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00010","volume":"134","author":"F Creed","year":"2001","unstructured":"Creed F, Ratcliffe J, Fernandez L, Tomenson B, Palmer S, Rigby C, et al: Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med. 2001, 134: 860-868.","journal-title":"Ann Intern Med"},{"key":"422_CR18","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1572-0241.2003.07296.x","volume":"98","author":"GF Longstreth","year":"2003","unstructured":"Longstreth GF, Wilson A, Knight K, Wong J, Chiou CF, Barghout V, et al: Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol. 2003, 98: 600-607. 10.1111\/j.1572-0241.2003.07296.x.","journal-title":"Am J Gastroenterol"},{"key":"422_CR19","doi-asserted-by":"publisher","first-page":"E109","DOI":"10.1097\/00007632-200203010-00017","volume":"27","author":"T Pincus","year":"2002","unstructured":"Pincus T, Burton AK, Vogel S, Field AP: A systematic review of psychological factors as predictors of chronicity\/disability in prospective cohorts of low back pain. Spine (Phila Pa 1976). 2002, 27: E109-E120.","journal-title":"Spine (Phila Pa 1976)"},{"key":"422_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2474-7-72","volume":"7","author":"DP Ritzwoller","year":"2006","unstructured":"Ritzwoller DP, Crounse L, Shetterly S, Rublee D: The association of comorbidities, utilization and costs for patients identified with low back pain. BMC Musculoskelet Disord. 2006, 7: 72-10.1186\/1471-2474-7-72.","journal-title":"BMC Musculoskelet Disord"},{"key":"422_CR21","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1001\/archinte.164.16.1773","volume":"164","author":"BM Spiegel","year":"2004","unstructured":"Spiegel BM, Gralnek IM, Bolus R, Chang L, Dulai GS, Mayer EA, et al: Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med. 2004, 164: 1773-1780. 10.1001\/archinte.164.16.1773.","journal-title":"Arch Intern Med"},{"key":"422_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/gut.2008.163162","volume":"58","author":"AC Ford","year":"2009","unstructured":"Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P: Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut. 2009, 58: 367-378. 10.1136\/gut.2008.163162.","journal-title":"Gut"},{"key":"422_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jpsychores.2008.02.016","volume":"64","author":"F Creed","year":"2008","unstructured":"Creed F, Tomenson B, Guthrie E, Ratcliffe J, Fernandes L, Read N, et al: The relationship between somatisation and outcome in patients with severe irritable bowel syndrome. J Psychosom Res. 2008, 64: 613-620. 10.1016\/j.jpsychores.2008.02.016.","journal-title":"J Psychosom Res"},{"key":"422_CR24","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1136\/gut.2007.119446","volume":"56","author":"R Spiller","year":"2007","unstructured":"Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, et al: Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007, 56: 1770-1798. 10.1136\/gut.2007.119446.","journal-title":"Gut"},{"key":"422_CR25","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology. 2006, 130: 1480-1491. 10.1053\/j.gastro.2005.11.061.","journal-title":"Gastroenterology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-10-31.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-10-31\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-10-31","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-10-31.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T06:09:48Z","timestamp":1630476588000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-10-31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,17]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["422"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-10-31","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,17]]},"assertion":[{"value":"13 October 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"31"}}